Dementia with Lewy Bodies and Parkinson's Disease Dementia

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Second Edition

Volumn , Issue , 2011, Pages 224-237

  Ince, Paul G ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

synucleinopathy; Alzheimer's disease; Dementia with Lewy bodies; Lewy bodies; Lewy neurites; Neurochemistry; Neurofibrillary tangles; Parkinson's disease dementia; Senile plaques; Tau

Indexed keywords

EID: 84865971066     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444341256.ch22     Document Type: Chapter

References (120)

1. Aarsland D, Londos E, Ballard C. Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity. Int Psychogeriatr, 2009; 21: 216-219.
2. McKeith I. Commentary: DLB and PDD: the same or different? Is there a debate? Int Psychogeriatr 2009; 21: 220-224.
3. Revuelta GJ, Lippa CF. Dementia with Lewy bodies and Parkinson's disease dementia may best be viewed as two distinct entities. Int Psychogeriatr 2009; 21: 213-216.
4. Tsuboi Y, Uchikado H, Dickson DW. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology. Parkinsonism Relat Disord 2007; 13 Suppl 3: S221-S224.
5. Kosaka K, Mehraein P. Dementia-parkinsonism with numerous Lewy bodies and senile plaques in cerebral cortex. Arch Psychiatr Nervenkr 1979; 226: 241-250.
6. Okazaki H, Lipkin L, Aronson SM. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 1961; 20: 237-244.
7. Ince P, Perry E, Morris C. Dementia with Lewy bodies: a distinct non-Alzheimer dementia? Brain Pathology 1998; 8: 299-324.
8. McKeith IG, Dickson DW, Lowe J et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 2005; 65: 1863-1872.
9. McKeith IG, Galasko D, Kosaka K et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology 1996; 47: 1113-1124.
10. Lennox G, Lowe J, Morrell K, Landon M, Mayer RJ. Antiubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry 1989; 52: 67-71.
11. Yamada T, Hattori H, Miura A, Tanabe M, Yamori Y. Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population. Psychiatry Clin Neurosci 2001; 55: 21-25.
12. Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG. Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 2008; 70: 1042-1048.
13. Wakisaka Y, Furuta A, Tanizaki Y, Kiyohara Y, Iida M, Iwaki T. Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol 2003; 106: 374-382.
14. Parkkinen L, Soininen H, Laakso M, Alafuzoff I. a-Synuclein pathology is highly dependent on the case selection. Neuropathol Appl Neurobiol 2001; 27: 314-325.
15. Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005; 20: 1255-1263.
16. Levy G, Schupf N, Tang M et al. Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol 2002; 51: 722-729.
17. Polymeropoulos MH. Autosomal dominant Parkinson's disease and a-synuclein. Ann Neurol 1998; 44 [ Suppl 1 ]: S63-S64.
18. Harrington CR, Louwagie J, Rossau R et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Signifcance for etiological theories of Alzheimer's disease. Am J Path 1994; 145: 1472-1484.
19. Kawanishi C, Suzuki K, Odawara T et al. Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease. J Neurol Sci 1996; 136: 140-142.
20. Lamb H, Christie J, Singleton AB et al. Apolipoprotein E and alpha-1 anti-chymotrypsin polymorphism genotyping in Alzheimer's disease and Dementia with Lewy bodies: distinctions between diseases. Neurology 1998; 50: 388-391.
21. Olichney JM, Hansen LA, Galasko D et al. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996; 47: 190-196.
22. Mattila PM, RöttyäM, Torikka H, Dickson DW, Rinne JO. Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease. Acta Neuropathol 1998; 95: 576-582.
23. Singleton A, Gibson A, Edwardson J, McKeith IG, Morris CM. Butyrylcholinesterase K: an association with dementia with Lewy bodies. Lancet 1998; 351: 1818.
24. Singleton A, Gibson A, McKeith IG, Ballard CG, Edwardson JA, Morris CM. Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neurosci Lett 2001; 303: 33-36.
25. Singleton AB, Lamb H, Leake A et al. No association between a polymorphism in the presenilin 1 gene and dementia with Lewy bodies. Neurorep 1997; 8: 3637-3639.
26. Singleton A, Gibson A, McKeith IG et al. Alpha-2-macroglobulin polymorphisms in alzheimer's disease and dementia with Lewy bodies. Neurorep 1999; 10: 1507-1510.
27. Xu W, Liu L, Emson P et al. The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies. Neurorep 2000; 10: 297-299.
28. Furuno T, Kawanishi C, Iseki E et al. No evidence of association between CYP2D6 polymorphisms among Japenese and Dementia with Lewy bodies. Psychiatr Clin Neurosci 2001; 55: 89-92.
29. Tanaka S, Chen X, Xia Y et al. Association of CYP2D microsatellite polymorphism and dementia with Lewy bodies. Neurology 1998; 50: 1556-1562.
30. Atkinson A, Singleton AB, Steward A et al. CYP2D6 is associated Parkinson's disease but not dementia with Lewy bodies or Alzheimer's disease. Pharmacogenet 1999; 9: 31-35.
31. Woo S, Hansen L, Yu X, Mallory M, Masliah E. Alternative splicing patterns of CYP2D genes in human brain and neurodegenerative diseases. Neurology 1999; 53: 1570-1572.
32. Lippa C, Fujiwara H, Mann D et al. Lewy bodies contain altered a-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998; 153: 1365-1370.
33. Janssen J, Lantos P, Fox N et al. Autopsy-confirmed familial early-onset Alzheimer disease caused by the L153V presenilin mutation. Arch Neurol 2001; 58: 953-958.
34. Lippa C, Schmidt M, Lee VM, Trojanowski JQ. Antibodies to a-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheime's disease. Ann Neurol 1999; 45: 353-357.
35. Calderon J, Perry R, Erzinclioglu S, Berrios GE, Dening TR, Hodges JR. Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease. J Neurol Neurosurg Psychiatr 2001; 70: 157-164.
36. McKeith IG, Ballard CG, Perry RH et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000; 54: 1050-1058.
37. Ballard C, Jacoby R, Del Ser T et al. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with Lewy bodies. Am J Psychiat 2004; 161: 843-849.
38. Serby M, Brickman A, Haroutunian V et al. Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer's disease. Am J Geriatr Psychiat 2003; 11: 371-374.
39. McKenzie JE, Edwards RJ, Gentleman SM et al. A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of the Lewy body type. Acta Neuropathol 1996; 91: 526-529.
40. Ballard C, O'Brien J, Morris CM et al. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Ger Psychiatr 2001; 16: 499-503.
41. Galloway PH, Sahgal A, McKeith IG et al. Visual pattern recognition memory and learning deficits in senile dementias of Alzheimer and Lewy body types. Dement Geriatr Cogn Disord 1992; 3: 101-107.
42. Sahgal A, Galloway PH, McKeith IG et al. Matching-to-sample deficits in patients with senile dementias of the Alzheimer and Lewy body types. Arch Neurol 1992; 49: 1043-1046.
43. Sahgal A, Gallowy PH, McKeith IG, Edwardson JA, Lloyd S. A comparative study of attentional deficits in senile dementias of Alzheimer and Lewy body types. Dement Geriatr Cogn Disord 1992; 3: 350-354.
44. Sahgal A, McKeith IG, Galloway PH, Tasker N, Steckler T. Do differences in visuospatial ability between senile dementia of the Alzheimer and Lewy body types reflect differences solely in mnemonic function. J Clin Exp Neuropsychol 1995; 17: 35-43.
45. Salmon DP, Galasko D, Hansen LA et al. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cognition 1996; 31: 148-165.
46. Lambon R, Powell J, Howard D, Whitworth AB, Garrard P, Hodges JR. Semantic memory is impaired in both dementia with Lewy bodies and dementia of Alzheimer's type: a comparative neuropsychological study and literature review. J Neurol Neurosurg Psychiatry 2001; 70: 149-156.
47. Ballard C, O'Brien J, Swann A, Thompson P, Neill D, McKeith IG. The natural history of psychosis and depression in dementia with Lewy bodies ad Alzheimer's disease: persistence in new cases over 1 year of follow-up. J Clin Psychiatry 2001; 62: 46-49.
48. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type. Psychol Med 1992; 22: 911-922.
49. McShane R, Gedling K, Reading M, McDonald B, Esiri MM, Hope T. Prospective study of relations between cortical Lewy bodies poor eyesight and hallucinations in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1995; 59: 185-188.
50. Ballard C, Walker M, O'Brien J, Rowan E, McKeith I. The characterisation and impact of ' fluctuating'cogntion in dementia with Lewy bodies and Alzheimer's disease. Int J Ger Psych 2001; 16: 494-498.
51. Louis ED, Klatka LA, Lui Y, Fahn S. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology 1997; 48: 376-380.
52. Ballard C, McKeith I, Burn D et al. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurol Scand 1997; 96: 366-371.
53. Luginger E, Seppi K, Litvan I et al. Associated alzheimer pathology modifies the natural history of dementia with Lewy bodies: a clonicopathological study. Mov Disord 2000; 15 (Suppl): 226.
54. Ballard C, O'Brien J, Swann A et al. One year follow up of Parkinsonism in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2000; 11: 219-222.
55. McKeith IG, Fairbairn A, Perry RH, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992; 305: 673-678.
56. Ballard C, Shaw F, Lowery K, McKeith I, Kenny R. The prevalence, assessment and associations of falls in Dementia with Lewy bodies. Dement Geriatr Cogn Disord 1999; 10: 97-103.
57. Imamura T, Hirono N, Hashimoto M et al. Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer's disease. Eur J Neurol 2000; 7: 77-79.
58. Ballard C, Shaw F, McKeith I, Kenny R. High prevalence of neurovascular instability in neurodegnerative dementias. Neurology 1998; 51: 1760-1762.
59. Arai K, Kato N, Kashiwado KI, Hattori T. Pure autonomic failure in association with human alpha-synucleinopathy. Neurosci Lett 2000; 296: 171-173.
60. Kaufmann H, Hague K, Perl D. Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure. Neurology 2001; 56: 980-981.
61. Perry R, McKeith I, Perry E. Lewy body dementia-clinical, pathological and neurochemical interconnections. J Neural Transm (Suppl) 1997; 51: 95-109.
62. Boeve BF, Dickson DW, Olson EJ et al. Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med 2007; 8: 60-64.
63. Burton EJ, Barber R, Mukaetova-Ladinska EB et al. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 2009; 132: 195-203.
64. O'Brien J, Paling S, Barber R et al. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD and vascualr dementia. Neurology 2001; 56: 1386-1388.
65. Imamura T, Ishii K, Hirono N et al. Occipital glucose metablism in dementia with Lewy bodies with and without Parkinsonism: a study using positron emission tomography. Dement Geriatr Cogn Disord 2001; 12: 194-197.
66. Lobotesis K, Fenwick J, Phipps A et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001; 56: 643-649.
67. Walker Z, Jaros E, Walker RW et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry 2007; 78: 1176-1181.
68. Kashihara K, Ohno M, Kawada S, Okumura Y. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies. J Nucl Med 2006; 47: 1099-1101.
69. Kanemaru K, Kameda K, Yamanouchi H et al. Decreased CSF amyloid ß 42 and normal tau levels in dementia with Lewy bodies. Neurology 2000; 54: 1875-1876.
70. Briel R, McKeith IG, Barker W et al. EEG findings in Dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999; 66: 401-403.
71. Cordato N, Halliday G, Harding A, Hely MA, Morris JG. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann Neurol 2000; 47: 718-720.
72. Gómez-Tortosa E, Sanders J, Newell K, Hyman BT. Cortical neurons expressing calcium binding proteins are spared in dementia with Lewy bodies. Acta Neuropathol 2001; 101: 36-42.
73. Wakabayashi K, Hansen LA, Masliah E. Cortical Lewy body-containing neurons are pyramidal cells: laser scanning confocal imaging of double-immunolabelled sections with anti-ubiquitin. Acta Neuropathol 1995; 89: 404-408.
74. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
75. Alafuzoff I, Ince PG, Arzberger T et al. Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 2009; 117: 635-652.
76. Jellinger KA, Attems J. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 2008; 115: 427-436.
77. Jellinger KA. Pathological substrate of dementia in Parkinson's disease-its relation to DLB and DLBD. Parkinsonism Relat Disord 2006; 12: 119-120.
78. Kövari E, Gold G, Herrmann F et al. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Acta Neuropath 2003; 106: 83-88.
79. Alvord EC, Forno LS, Kusske JA, Kauffman RJ, Rhodes JS, Goetowski CR. The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brain stem. Adv Neurol 1974; 5: 175-193.
80. Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J. Amygdala pathology in Parkinson's disease. Acta Neuropathol 1994; 88: 493-500.
81. de Vos RA, Jansen EN, Stam FC, Ravid R, Swaab DF. ' Lewy Body Disease': clinicopatholgical correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 1995; 97: 13-22.
82. Den Hartog Jager WA, Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 1960; 23: 283-290.
83. Parkkinen L, Pirttilä T, Tervahauta M, Alafuzoff I. Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject. Neuropathology 2005; 25: 304-314.
84. Parkkinen L, Soininen H, Alfuzoff I. Regional distribution of alphasynuclein pathology in unimpaired aging and Alzheimer's disease. J Neuropahol Exp Neurol 2003; 62: 363-367.
85. Uchikado H, Lin WL, DeLucia MW, Dickson DW. Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 2006; 65: 685-697.
86. Kalaitzakis ME, Pearce RK, Gentleman SM. Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 2009; 461: 12-15.
87. Hansen LA, Masliah E, Terry RD, Mirra SS. A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol 1989; 78: 194-201.
88. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type: a clinically and neuropatholgically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990; 95: 119-139.
89. Hansen LA, Samuel W. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 1997; 48: 126-132.
90. Mirra SS, Heyman A, McKeel D et al. The consortium to establish a registry of Alzheimer's disease (CERAD) Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
91. Hely M, Reid W, Halliday G et al. Diffuse Lewy body disease: clinical features in nine cases without co-existent Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 60: 531-538.
92. Hansen LA. The Lewy body variant of Alzheimer disease. J Neural Transm (Suppl) 1997; 51: 83-93.
93. Ince P, Irving D, MacArthur F, Perry RH. Quantitative neuropathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy bodt type, Parknison's disease and non-demented elderly control patients. J Neurol Sci 1991; 106: 142-152.
94. Strong C, Anderton BH, Perry RH, Perry EK, Ince PG, Lovestone S. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer's disease: evidence that the disorders are distinct. Alz Dis Assoc Disord 1995; 9: 218-222.
95. Alafuzoff I, Parkkinen L, Al-Sarraj S et al. Assessment of immunohistochemically detectable a-synuclein pathology. A study of the BrainNet Europe Consortium. J Neuropath Exp Neurol 2008; 67: 125-143.
96. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. a-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and Dementia with Lewy bodies. Proc Natl Acad Sci USA 1998; 95: 6469-6473.
97. Arima K, Mizutani T, Alim M et al. NACP/alpha synuclein and tau constitute two distinctive subsets of filaments in the same inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabelling fluorescence and electron microscopy studies. Acta Neuropathol 2000; 100: 115-121.
98. Dickson DW, Schmidt ML, Lee VM, Zhao ML, Yen SH, Trojanowski JQ. Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropathol 1994; 87: 269-276.
99. Masliah E. Recent advances in the understanding of the role of synaptic proteins in Alzheimer's disease and other neurodegenerative disorders. J Alz Dis 2001; 2001: 121-129.
100. Revuelta GJ, Rosso A, Lippa CF. Neuritic pathology as a correlate of synaptic loss in dementia with lewy bodies. Am J Alz Dis Other Demen 2008; 23: 97-102.
101. Terada S, Ishizu H, Haraguchi T et al. Tau-negative astrocytic star-like inclusions and coiled bodies in dementia with Lewy bodies. Acta Neuropathol 2000; 100: 464-468.
102. Rozemuller A, Eikelenboom P, Theeuwes J, Jansen Steur EN, de Vos RA. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies. Acta Neuropathol 2000; 100: 701-708.
103. Perry EK, Haroutunian V, Davis KL et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport 1994; 5: 747-749.
104. Shimada H, Hirano S, Shinotoh H et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 2009; 73: 273-278.
105. Perry EK, Marshall E, Kerwin J et al. Evidence of a monoaminergic: cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem 1990; 55: 1544-1546.
106. Langlais PJ, Thal L, Hansen L, Galasko D, Alford M, Masliah E. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology 1993; 43: 1927-1934.
107. Perry EK, Marshall E, Perry RH et al. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alz Dis Rel Disord 1990; 4: 87-95.
108. Perry EK, Smith CJ, Court JA, Perry RH. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J Neural Transm 1990; 2: 149-158.
109. Shiozaki K, Iseki E, Uchiyama H et al. Alterations in muscarinic acetylcholine receptor subtypes in diffues Lewy body disease: relation to Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999; 67: 209-213.
110. Jellinger K. Morphological substrates of dementia in parkinsonism. a critical update. J Neural Transm 1997; 52: 57-82.
111. Martin-Ruiz C, Court J, Lee M et al. Nicotinic receptors in dementia of Alzheimer. Lewy body and vascular types. Acta Neurol Scand 2000; 102: 34-41.
112. Piggott ME, Marshall EF, Thomas N et al. Striatal dopamine activities in Dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease; rostro-caudal distribution. Brain 1999; 122: 1449-1468.
113. Court J, Spurden D, Lloyd S et al. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. J Neurochem 1999; 73: 1590-1597.
114. Hamilton R. Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using a-synuclein immunohistochemistry. Brain Pathol 2000; 10: 378-384.
115. Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y. Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease and its re;lationship to tau aggregation. Brain Res 2001; 888: 287-296.
116. Marui W, Iseki E, Nakai T et al. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci 2002; 195: 153-159.
117. Del Sur T, Hachinski V, Merskey H, Muñoz DG. Clinical and pathological features of two groups of patients with dementia with Lewy bodies: effect of co-existing Alzheimer-type lesion load. Alzheimer's Dis Assoc Disord 2001; 15: 31-44.
118. McKeith IG, Fairbairn AF, Perry RH, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type. Br J Psychiatr 1994; 165: 324-332.
119. McKeith I, Del Sur T, Spano P et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled, international study. Lancet 2000; 356: 2031-2036.
120. Kramer ML, Schulz-Schaeffer WJ. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 2007; 27: 1405-1410.